SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Paul Graham Wyatt · Study

Home/Author

Paul Graham Wyatt

5 works· latest 2021· 2 institutionscluster: provisionalORCID 0000-0002-0397-245X

h-index5

i105

Citations283

Works here5

02

05

10

21

Most cited in this library

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR2005 · 67 citations
The Tuberculosis Drug Accelerator at year 10: what have we learned?2021 · 61 citations
Drug discovery in academia: the third way?2010 · 60 citations
2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics2005 · 53 citations
Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives2002 · 42 citations

Works

5 shown

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nature Medicine·2021·37 authors·Open access

61citations

Drug discovery in academia: the third way?

Expert Opinion on Drug Discovery·2010·2 authors·Open access

60citations

2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics

Journal of Medicinal Chemistry·2005·11 authors

53citations

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR

Bioorganic & Medicinal Chemistry Letters·2005·12 authors

67citations

Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives

Bioorganic & Medicinal Chemistry Letters·2002·12 authors

42citations